生命科学资讯

Lilly goes back to Nimbus for an oral obesity drug in $55M deal

Thermo Fisher Scientific to Present at the J.P. Morgan 2026 Healthcare Conference - Yahoo Finance

PharmaVoice’s Crystal Ball: Market and policy forces shaping the industry

Thermo Fisher Scientific Launches CorEvitas Obesity Registry to Advance Real-World Evidence in Treatment Outcomes - The AI Journal

Thermo Fisher Scientific Launches CorEvitas Obesity Registry to Advance Real-World Evidence in Treatment Outcomes - Business Wire

Arrowhead’s RNAi obesity programs head to Phase 2 after encouraging early data

FDA cites severe liver injury risk, unclear benefit behind Sanofi's MS drug rejection

UK biotech eyes $1B deal to enable eye gene therapy to be delivered in doctors' offices

Robeco Institutional Asset Management B.V. Buys 233,200 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat

Evercore ISI Upgrades Agilent Technologies to Outperform From In Line, Adjusts PT to $160 From $155 - marketscreener.com

Why Agilent (A) Stock Is Up Today - Yahoo Finance

10x Genomics Stock (+10%): Analyst Upgrades Spark a Short Cover Rally - Trefis

Financings for Jan. 6, 2026

Appointments and advancements for Jan. 6, 2026

Other news to note for Jan. 6, 2026

Regulatory actions for Jan. 6, 2026

Why Illumina (ILMN) Is Up 6.5% After Advancing Grail Divestiture Plan And What's Next - Yahoo Finance

Why Illumina (ILMN) Is Up 6.5% After Advancing Grail Divestiture Plan And What's Next - Yahoo Finance UK

Thermo Fisher Scientific (NYSE:TMO) Sets New 52-Week High - Should You Buy? - MarketBeat

Evercore ISI Group Upgrades Agilent Technologies (A) - Nasdaq